Zdrowie i gospodarka · 26/06/2026
FDA Extends Effective Date of Drug Efficacy Study Implementation Notice
The FDA is extending the effective date of a notice related to estrogen-androgen fixed-combination drug products by 90 days, from June 26, 2026, to September 24, 2026, to allow sufficient time for consideration of issues raised by interested parties.